
Riel Pharma LLP
About Riel Pharma LLP
Data last updated:
Riel Pharma LLP is a limited liability partnership (LLP) based in Arambagh, West Bengal, India. It operates in the chemicals and chemical products segment of the chemicals sector. It was incorporated on 13 May 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Kolkata, under LLPIN AAW-9985.
The LLP has a total obligation of contribution of βΉ1 Lakh. It is led by designated partners Sk Rejaul Bari and Lipi Chatterjee.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at W/N 5 Rabindrapally Opposite Electric Supply Office, Arambagh, West Bengal, India β 712601.
Company details
Contact details
Riel Pharma LLP's registered office is in Arambagh, West Bengal.
- Registered AddressW/N 5 Rabindrapally Opposite Electric Supply Office, Arambagh, West Bengal, India β 712601
- IndustryChemicals, Chemicals and Chemical Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Riel Pharma LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Riel Pharma LLP, buy the company report.
Designated partners of Riel Pharma LLP
Riel Pharma has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sk Rejaul Bari | Designated Partner | 13 May 2021 | 5 Years 6 Months | Current |
| Lipi Chatterjee Also directs: Rhine Pharma Private Limited | Designated Partner | 26 Dec 2022 | 3 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Riel Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riel Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Riel Pharma LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Riel Pharma LLP has 3 designated partner changes on record since 2021: 2 appointments and 1 cessation. The latest: Bikash Shaw ceased to be Designated Partner on 26 Dec 2022.
Frequently asked questions
Riel Pharma is an active limited liability partnership based in Arambagh, West Bengal, India. The LLP works in chemicals and chemical products, within the chemicals industry. It was incorporated on 13 May 2021 (5+ years old) and is registered under LLPIN AAW-9985.
Riel Pharma has 2 current designated partners:
- Sk Rejaul Bari - Designated Partner
- Lipi Chatterjee - Designated Partner
The latest financial statements of Riel Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2022 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Riel Pharma is AAW-9985. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Riel Pharma was incorporated on 13 May 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
Bikash Shaw ceased to be Designated Partner on 26 Dec 2022. Lipi Chatterjee was appointed as Designated Partner on 26 Dec 2022. Sk Rejaul Bari was appointed as Designated Partner on 13 May 2021.
The registered office of Riel Pharma is at WN 5 Rabindrapally Opposite Electric Supply Office, Arambagh, West Bengal, India β 712601.
Riel Pharma operates in the chemicals industry, in the chemicals and chemical products segment.
Riel Pharma can be reached at its registered office: WN 5 Rabindrapally Opposite Electric Supply Office, Arambagh, West Bengal, India β 712601.
Riel Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Kolkata.

